Skip to main content
Top of the Page

Organoids by Southwest (OXSW)


OXSW, the U.S. subsidiary of OrganoidScience, is dedicated to advancing organoid-based pipeline development. Based in Texas, our team leverages advanced organoid platforms to identify, validate, and accelerate next-generation therapies. With a strong foundation in innovation and collaboration, OXSW is committed to shaping the future of biomedical research and therapeutic development.

Therapeutic Developer


Back to Top